Spikevax Injection, Suspension
NDC Package 80777-112-93
Package Information
Spikevax (covid-19 vaccine, mrna) injection is a vaccine administered via intramuscular route. This formulation utilizes a injection, suspension delivery system. Marketed by Moderna Us, Inc., this product is identified by NDC 80777-112 and is authorized under FDA application BLA125752.
Identification & Billing
- RxCUI: 2691172 - SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.25 ML Prefilled Syringe, 6m through 11y
- RxCUI: 2691172 - 0.25 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe
- RxCUI: 2691175 - SARS-CoV-2 (COVID-19) vaccine 2024-2025, mRNA-1273 OMICRON (KP.2) 0.5 ML Prefilled Syringe, 12y+
- RxCUI: 2691175 - 0.5 ML SARS-CoV-2 (COVID-19) vaccine, mRNA-1273 OMICRON (KP.2) 0.1 MG/ML Prefilled Syringe
- RxCUI: 2691181 - spikevax 2024-2025 vaccine, 0.5 ML Prefilled Syringe, 12y+
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 80777 - Moderna Us, Inc.
- 80777-112 - Spikevax
- 80777-112-93 - 10 SYRINGE, PLASTIC in 1 CARTON / .5 mL in 1 SYRINGE, PLASTIC (80777-112-01)
- 80777-112 - Spikevax
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (80777-112). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 80777-112-93 identifies a specific commercial package of 10 syringe, plastic in 1 carton / .5 ml in 1 syringe, plastic (80777-112-01) of Spikevax, a vaccine label labeled by Moderna Us, Inc.. This injection, suspension is formulated for intramuscular use and contains cx-051869 as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Moderna Us, Inc. on August 27, 2025. The current certification is valid through December 31, 2026.
How is this Moderna Us, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 80777011293. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.